Concepedia

W. Kalow

WK

154

Publications

11.3K

Citations

55

H-Index

1951

Active since

Affiliations

University of Toronto(Current)

W. Kalow is an author at University of Toronto specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryPhysiologyBioanalysisToxicologyMetabolismMetabolomicsPharmacotherapyClinical Chemistry

Publications per year

1951–2008

154

Publications

154

Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver

Toshifumi Aoyama, Saki Yamano, David J. Waxman et al. · Journal of Biological Chemistry · 1989 · 481 citations · Full text

A METHOD FOR THE DETECTION OF ATYPICAL FORMS OF HUMAN SERUM CHOLINESTERASE. DETERMINATION OF DIBUCAINE NUMBERS

W. Kalow, K. Genest · Canadian Journal of Biochemistry and Physiology · 1957 · 471 citations

Esterase Inhibition, Pharmacotherapy, Experimental Pharmacology +18

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

Lie Gu, Frank J. Gonzalez, W. Kalow et al. · Pharmacogenetics · 1992 · 324 citations

Molecular Pharmacology, Cyp2e1 Activities, Biochemistry +14

METABOLIC ERROR OF MUSCLE METABOLISM AFTER RECOVERY FROM MALIGNANT HYPERTHERMIA

W. Kalow, Beverley A. Britt, M.E. Terreau et al. · The Lancet · 1970 · 316 citations

Metabolic Syndrome, Energy Metabolism, Kinesiology +8

ON DISTRIBUTION AND INHERITANCE OF ATYPICAL FORMS OF HUMAN SERUM CHOLINESTERASE, AS INDICATED BY DIBUCAINE NUMBERS

W. Kalow, N. Staron · Canadian Journal of Biochemistry and Physiology · 1957 · 300 citations

Serum Cholinesterase, Genetics, Molecular Genetics +21

Rows per page

1–5 of 154